Bpifrance

Bpifrance is a financial institution dedicated to supporting companies throughout their development stages, particularly those preparing for stock market listing and seeking credit equity. The organization provides a range of financial solutions, including financing, innovation assistance, and capital investment. By integrating various entities such as OSEO and CDC Entreprises, Bpifrance aims to deliver tailored financial support that addresses the specific needs of businesses. The institution is committed to fostering innovation and helping companies transition toward sustainable growth, ensuring they are well-equipped to face future challenges.

Laurent Arthaud

Managing Director

Marion Aubry

Investment Director

Emmanuel Audouard

Director of Transverse Venture Capital Investments Division

Benoit Barteau Ph.D

Investment Director

Nicolas Berdou

Investment Director, Defense Expert

Clarisse Blandin

Investment Director

Edouard Combette

Investment Director

Charlotte Corbaz

Deputy Director of the Large Venture Fund and Deputy Managing Director

Nicolas Dardenne

Senior Investment Director, Normandy (Caen Rouen)

Arnaud Despoisse

Director of Occitanie Participations

Philippe Dutheil

Investment Director

Mailys Ferrere

Director of Large Venture Investments

Jean-Marie Fougeray

Senior Investment Director, Brittany

Paul-Francois Fournier

Executive Director, Innovation Department

Pierre Gillet

Investment Director

Vanessa Giraud

Managing Director

Gwenaël Hamon

Senior Investment Director

Laurent Higueret Ph.D

Senior Investment Director

Louis Janneau

Investment Director and Fund Manager

Magali Joessel

Director of Funds

So-Yeon Koo

Senior Investment Manager

Jérôme Langlade

Investment Director Aquitaine / Limousin / Poitou-Charentes

Eric Lefebvre

Director

Stephane Lefevre-Sauli

Senior Investment Director

Arnaud Legardeur

Investment Director

Chahra Louafi

Senior Investment Director

Elyssa Maufras du Châtellier

Investment Director

Quentin Mayolle

Senior Investment Officer

Serge Mesguich

Director of FIT

Laure Michel

Investment Director

Louis Molis

Investment Director

Jean-Francois Morin

Investment Director

Sébastien Moynot

Director

Adrien Muller

Investment Director

Adrien Néel

Investment Director

Axel Piriou

Director of Investments

Olivier Rameil

Senior Investment Director / VC seed

Vincent Roque

Director

Thibaut Roulon Ph.D

Investment Director

Gilles Schang

Deputy Director

Claire Waché

Senior Investment Officer

Past deals in Pets

Dalma

Series B in 2025
Dalma is an animal insurance company focused on providing pet owners with transparent, subscription-based health insurance. The company’s platform is designed to be user-friendly, offering coverage that reimburses costs associated with illnesses, injuries, and preventive care for pets. In addition to financial support, Dalma also provides customers with free unlimited access to veterinary advice and tips, facilitating better care for their animals. Through its digital approach, Dalma aims to simplify the insurance process for pet owners and enhance their overall experience in managing their pets' health.

Vetbiolix

Venture Round in 2024
Vetbiolix is a veterinary biotechnology company dedicated to developing innovative therapeutic solutions for dogs and cats. The company focuses on the clinical development of first-in-class drug candidates aimed at treating and preventing diseases affecting pets, including periodontitis, osteoarthritis, and gut motility disorders. By prioritizing the creation of effective treatments for common health issues, Vetbiolix aims to enhance the quality of life for pets and their owners.

Vetbiolix

Seed Round in 2024
Vetbiolix is a veterinary biotechnology company dedicated to developing innovative therapeutic solutions for dogs and cats. The company focuses on the clinical development of first-in-class drug candidates aimed at treating and preventing diseases affecting pets, including periodontitis, osteoarthritis, and gut motility disorders. By prioritizing the creation of effective treatments for common health issues, Vetbiolix aims to enhance the quality of life for pets and their owners.

Enalees

Series A in 2024
Enalees develops molecular diagnostic tests for animals that can be used directly by veterinarians, enabling rapid on-site detection of infectious diseases in pets and livestock. The company provides fast, easy-to-use diagnostic kits with integrated reagents and a portable reader, designed for use in clinics and field settings to support timely and accurate treatment decisions.

Dogami

Seed Round in 2022
Dogami is a web3 entertainment company developing a blockchain-based game centered on 3D NFT dog avatars. The platform combines non-fungible token gaming with ownership and monetization, enabling players to adopt, raise, and interact with their virtual dogs within a shared environment called the Petaverse. The game emphasizes play-to-earn mechanics, allowing participants to earn the native cryptocurrency DOGA through in-game activities as they aim to breed rare and desirable dogs. By integrating NFT ownership with a mass-market gaming experience, Dogami seeks to provide a digital pet world where users can socialize, collect unique canine companions, and participate in an emerging ecosystem around virtual pets.

Otherwise

Seed Round in 2017
Otherwise is a pioneering collaborative insurance broker based in France, focusing on providing peer-to-peer insurance solutions. The company creates a platform that connects individuals with shared insurance needs, allowing them to pool resources for better coverage and cost efficiency. By leveraging behavioral analysis alongside community management and machine learning, Otherwise facilitates a significant reduction in overall insurance costs for its members. Additionally, the platform offers tailored animal insurance services, featuring transparent pricing models that accommodate individual budgets. These services include veterinary assistance and collaborative bonuses, enabling policyholders to seamlessly manage benefits through compulsory plans and advance cost options.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.